AI assistant
SOLESENCE, INC. — Director's Dealing 2021
Sep 16, 2021
33563_dirs_2021-09-16_e24dbbfd-d0c3-46c3-81f9-76161628a579.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NANOPHASE TECHNOLOGIES Corp (NANX)
CIK: 0000883107
Period of Report: 2021-09-14
Reporting Person: Cureton Kevin (Chief Operating Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-09-14 | Common Stock | M | 52000 | $0.30 | Acquired | 52000 | Direct |
| 2021-09-14 | Common Stock | S | 2800 | $2.30 | Disposed | 49200 | Direct |
| 2021-09-15 | Common Stock | S | 5350 | $2.30 | Disposed | 43850 | Direct |
| 2021-09-16 | Common Stock | S | 17000 | $2.22 | Disposed | 26850 | Direct |
| 2021-09-16 | Common Stock | S | 1200 | $2.26 | Disposed | 25650 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-09-14 | Common Stock (right to purchase) | $0.30 | M | 52000 | Disposed | 2022-11-28 | Common Stock (52000) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Common Stock (right to purchase) | $0.415 | 2023-02-14 | Common Stock (48000) | 48000 | Direct |
| Common Stock (right to purchase) | $0.52 | 2024-02-13 | Common Stock (75000) | 75000 | Direct |
| Common Stock (right to purchase) | $0.44 | 2025-02-18 | Common Stock (50000) | 50000 | Direct |
| Common Stock (right to purchase) | $0.42 | 2026-02-23 | Common Stock (43500) | 43500 | Direct |
| Common Stock (right to purchase) | $0.68 | 2027-02-21 | Common Stock (50000) | 50000 | Direct |
| Common Stock (right to purchase) | $0.82 | 2028-05-23 | Common Stock (80000) | 80000 | Direct |
| Common Stock (right to purchase) | $0.51 | 2029-05-22 | Common Stock (16500) | 16500 | Direct |
| Common Stock (right to purchase) | $0.45 | 2027-06-18 | Common Stock (90000) | 90000 | Direct |
Footnotes
F1: Mr. Cureton has exercised shares from his November 28, 2012 option grant to avoid the risk of expiration. In light of the blackout requirements within the Company's Policy on Insider Trading, limited trading windows exist during which these transactions can be completed. Subsequent to exercise, he plans to sell some of the exercised shares reported herein in order to satisfy the costs of exercise and the required income tax withholdings.
F2: Mr. Cureton has exercised shares from his November 28, 2012 option grant to avoid the risk of expiration. In light of the blackout requirements within the Company's Policy on Insider Trading, limited trading windows exist during which these transactions can be completed. The sales reported herein were effected in order to satisfy the costs of exercise and the required income tax withholdings.
F3: Mr. Cureton has exercised shares from his November 28, 2012 option grant to avoid the risk of expiration. In light of the blackout requirements within the Company's Policy on Insider Trading, limited trading windows exist during which these transactions can be completed. Subsequent to exercise, he plans to sell some of the shares exercised in order to satisfy the costs of exercise and the required income tax withholdings.
F4: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments.